Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
OPNT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-0.05
vs 0.31
Q3.20
-92%
0.15
vs 1.97
Q4.20
N/A
-0.16
vs 0.2
Q1.21
N/A
-0.66
vs -0.40
Q2.21
+720%
0.31
vs -0.05
Q3.21
+273%
0.56
vs 0.15
Q4.21
+169%
0.11
vs -0.16
Q1.22
N/A
-2.43
vs -0.66
Q2.22
N/A
-2.31
vs 0.31
Q3.22
N/A
-1.92
vs 0.56
Sales Growth
YoY
Current
Estimates
Q2.20
-6%
6.3M vs 6.7M
Q3.20
-58%
8.6M vs 20.5M
Q4.20
+16%
8.3M vs 7.2M
Q1.21
+3%
4.3M vs 4.2M
Q2.21
+49%
9.3M vs 6.3M
Q3.21
+63%
14M vs 8.6M
Q4.21
+56%
13M vs 8.3M
Q1.22
-49%
2.2M vs 4.3M
Q2.22
-75%
2.3M vs 9.3M
Q3.22
+1138%
173.9M vs 14M
Return on Equity
QoQ
Q4.20
-2%
-0.02
vs 0.02
Q1.21
-8%
-0.08
vs -0.02
Q2.21
+5%
0.05
vs -0.08
Q3.21
+8%
0.08
vs 0.05
Q4.21
+2%
0.02
vs 0.08
Q1.22
-32%
-0.32
vs 0.02
Q2.22
-40%
-0.40
vs -0.32
Q3.22
-48%
-0.48
vs -0.40
Institutionnal Ownership
QoQ
Q1.21
30
30
vs 29
3%
Q2.21
26
26
vs 30
-13%
Q3.21
34
34
vs 26
31%
Q4.21
41
41
vs 34
21%
Q1.22
39
39
vs 41
-5%
Q2.22
32
32
vs 39
-18%
Q3.22
31
31
vs 32
-3%
Q4.22
37
37
vs 31
19%
seekingalpha.com
3 hours ago
seekingalpha.com
9 hours ago
investorplace.com
10 hours ago
prnewswire.com
12 hours ago
seekingalpha.com
14 hours ago
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
NASDAQ
Unprofitable
Unprofitable
Relative Strenght
25
Volume Buzz
678%
Earning Acce
Yes
Dist 52w H.
25%Quote Panel
Key Metrics
Relative Strength
OPNT
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Hold
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
Northland Securities
downgradePrevious: Not converted
2022-11-27
Now: Market Perform
Cantor Fitzgerald
downgradePrevious: Overweight
2022-11-22
Now: Neutral
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How OPNT compares to sector?
OPNT
31x
